SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?


To: JGoren who wrote (2261)7/7/1999 2:37:00 PM
From: Anthony Wong  Respond to of 2539
 
Cattle growth hormone ban likely to continue
Irish Times
Tuesday, July 6, 1999


By Kevin O'Sullivan, Environmental and Food Science
Correspondent

The failure by governments to agree on standards for the
controversial growth hormone, bovine somatrophin (BST), is
likely to make it much easier for the EU to renew its ban of the
Monsanto product, which boosts milk yields, later this year.

A meeting of the UN body that sets international food
standards, the Codex Alimentarius Commission, has failed to
secure agreement on a permissible maximum residue level
(MRL) for the product. BST, which is similar to a natural
growth hormone found in cattle, is genetically engineered by
the US biotech company.

The outcome of the meeting in Rome (which broke up at the
weekend) means governments will have more leeway in
deciding whether to allow the use of BST. The EU has a
moratorium on its use, primarily because of what it believes are
indications of animal welfare problems. Canadian health
authorities earlier this year rejected Monsanto's request for its
approval despite its widespread use in the US.

The US administration has for some time been seeking an
international agreement on a MRL for BST, but accepted the
outcome of the Codex meeting. The EU has, however, been
reviewing the scientific evidence on BST with every indication
it will renew its ban shortly.

Consumers International, a federation of 245 consumer
organisations in 110 countries, welcomed the outcome, calling
it "a victory for the health and safety of consumers".

Its director general, Mr Julian Edwards, said: "With this
decision Codex has taken an important step in listening to
consumer concerns. National governments will be able to act
to ensure their citizens are not forced to consume products
produced with the use of BST."

Consumers International believed the hormone had not been
proven safe. "The adoption of a standard would have asserted
the hormone was safe to use, and countries refusing to import
dairy products from countries where BST is used could be
brought before the World Trade Organisation on the grounds
they are creating a barrier to trade."

ireland.com:80/newspaper/ireland/1999/0706/hom11.htm